KS
Khushboo Singh
About Khushboo Singh
Data last updated:
Khushboo Singh is a Director at Genelife Clinical Research Private Limited (since 2021) and Designated Partner at Geneline Pharma Llp (since 2022). The companies operate in Research & Development and E-Commerce. The largest current company by reported revenue is Genelife Clinical Research Private Limited at ₹54.3 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Genelife Clinical Research Private Limited U73100MH2015PTC269061 | Director | 07 May 2021 | 2015 | ₹54.3 Lakh (FY 2024) | Active |
 Geneline Pharma Llp AAF-4276 | Designated Partner | 26 Nov 2022 | 2016 | Active |
Board colleagues of Khushboo Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dhirendra Vikram Singh | 07278140 | Genelife Clinical Research Private Limited , Geneline Pharma Llp | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Khushboo Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Khushboo Singh
Khushboo Singh currently holds 2 directorships: Genelife Clinical Research Private Limited (Director, since 07 May 2021, revenue ₹54.3 Lakh (FY 2024)); Geneline Pharma Llp (Designated Partner, since 26 Nov 2022).
Khushboo Singh was first appointed on 07 May 2021 as Director at Genelife Clinical Research Private Limited. The most recent appointment on record is 26 Nov 2022 at Geneline Pharma Llp.
The current boards of Khushboo Singh's companies include Dhirendra Vikram Singh (Genelife Clinical Research Private Limited).